These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19114723)

  • 1. Selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 for patients with metabolic syndrome: is the target liver, fat, or both?
    Stewart PM; Tomlinson JW
    Diabetes; 2009 Jan; 58(1):14-5. PubMed ID: 19114723
    [No Abstract]   [Full Text] [Related]  

  • 2. Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)--a promising drug target for the treatment of metabolic syndrome.
    Masuzaki H; Flier JS
    Curr Drug Targets Immune Endocr Metabol Disord; 2003 Dec; 3(4):255-62. PubMed ID: 14683456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 11beta-hydroxysteroid dehydrogenase type 1 and obesity.
    Morton NM; Seckl JR
    Front Horm Res; 2008; 36():146-164. PubMed ID: 18230901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-specific Cushing's syndrome uncovers a new target in treating the metabolic syndrome--11beta-hydroxysteroid dehydrogenase type 1.
    Stewart PM
    Clin Med (Lond); 2005; 5(2):142-6. PubMed ID: 15847006
    [No Abstract]   [Full Text] [Related]  

  • 5. Extra-adrenal regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1: physiological regulator and pharmacological target for energy partitioning.
    Walker BR
    Proc Nutr Soc; 2007 Feb; 66(1):1-8. PubMed ID: 17343766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 11-Beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) inhibitors in type 2 diabetes mellitus and obesity.
    Hughes KA; Webster SP; Walker BR
    Expert Opin Investig Drugs; 2008 Apr; 17(4):481-96. PubMed ID: 18363514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A potent and selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, SKI2852, ameliorates metabolic syndrome in diabetic mice models.
    Oh H; Jeong KH; Han HY; Son HJ; Kim SS; Lee HJ; Kim S; Sa JH; Jun HS; Ryu JH; Choi CS
    Eur J Pharmacol; 2015 Dec; 768():139-48. PubMed ID: 26519792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structures of 11β-hydroxysteroid dehydrogenase type 1 and their use in drug discovery.
    Thomas MP; Potter BV
    Future Med Chem; 2011 Mar; 3(3):367-90. PubMed ID: 21446847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of 11beta-HSD1: a potential treatment for the metabolic syndrome.
    St Jean DJ; Wang M; Fotsch C
    Curr Top Med Chem; 2008; 8(17):1508-23. PubMed ID: 19075762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of 11β-hydroxysteroid dehydrogenase 1 by carbenoxolone affects glucose homeostasis and obesity in db/db mice.
    Dhanesha N; Joharapurkar A; Shah G; Kshirsagar S; Dhote V; Sharma A; Jain M
    Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):69-77. PubMed ID: 22060140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 11β-Hydroxysteroid dehydrogenase type 1: potential therapeutic target for metabolic syndrome.
    Joharapurkar A; Dhanesha N; Shah G; Kharul R; Jain M
    Pharmacol Rep; 2012; 64(5):1055-65. PubMed ID: 23238463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipose tissue expression of 11beta-hydroxysteroid dehydrogenase type 1 in Cushing's syndrome and in obesity.
    Espíndola-Antunes D; Kater CE
    Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1397-403. PubMed ID: 18209879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortisol release from adipose tissue by 11beta-hydroxysteroid dehydrogenase type 1 in humans.
    Stimson RH; Andersson J; Andrew R; Redhead DN; Karpe F; Hayes PC; Olsson T; Walker BR
    Diabetes; 2009 Jan; 58(1):46-53. PubMed ID: 18852329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role and regulation of 11β-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome.
    Stimson RH; Walker BR
    Horm Mol Biol Clin Investig; 2013 Sep; 15(2):37-48. PubMed ID: 25436731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there sufficient evidence to consider the use of 11β-hydroxysteroid dehydrogenase type 1 inhibition in children?
    Fürst-Recktenwald S; Dörr HG; Quinkler M; Dötsch J; Stewart PM
    Clin Endocrinol (Oxf); 2012 Aug; 77(2):159-68. PubMed ID: 22486586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 11Beta-hydroxysteroid dehydrogenase type 1 in human disease: a novel therapeutic target.
    Tomlinson JW
    Minerva Endocrinol; 2005 Mar; 30(1):37-46. PubMed ID: 15877012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of hepatic 5α-reductase and 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue is associated with hyperinsulinemia in morbidly obese patients.
    Baudrand R; Domínguez JM; Carvajal CA; Riquelme A; Campino C; Macchiavello S; Bozinovic M; Morales M; Pizarro M; Solis N; Escalona A; Boza C; Arrese M; Fardella CE
    Metabolism; 2011 Dec; 60(12):1775-80. PubMed ID: 21704348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cortisol-activating enzyme 11β-hydroxysteroid dehydrogenase type 1 in skeletal muscle in the pathogenesis of the metabolic syndrome.
    Loerz C; Maser E
    J Steroid Biochem Mol Biol; 2017 Nov; 174():65-71. PubMed ID: 28765040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure based design of 11β-HSD1 inhibitors.
    Singh S; Tice C
    Curr Pharm Biotechnol; 2010 Nov; 11(7):779-91. PubMed ID: 20809895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-amino-1,3-thiazol-4(5H)-ones as potent and selective 11beta-hydroxysteroid dehydrogenase type 1 inhibitors: enzyme-ligand co-crystal structure and demonstration of pharmacodynamic effects in C57Bl/6 mice.
    Johansson L; Fotsch C; Bartberger MD; Castro VM; Chen M; Emery M; Gustafsson S; Hale C; Hickman D; Homan E; Jordan SR; Komorowski R; Li A; McRae K; Moniz G; Matsumoto G; Orihuela C; Palm G; Veniant M; Wang M; Williams M; Zhang J
    J Med Chem; 2008 May; 51(10):2933-43. PubMed ID: 18419108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.